Martin Currie Ltd. purchased a new position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) in the 4th quarter, HoldingsChannel reports. The firm purchased 28,664 shares of the semiconductor company’s stock, valued at approximately $13,912,000.
A number of other hedge funds and other institutional investors have also recently modified their holdings of SNPS. Arrowstreet Capital Limited Partnership acquired a new position in Synopsys in the fourth quarter valued at $1,678,000. Allianz SE bought a new position in shares of Synopsys in the 4th quarter worth about $2,371,000. Allstate Corp acquired a new position in shares of Synopsys in the 4th quarter valued at about $2,200,000. Maridea Wealth Management LLC bought a new stake in shares of Synopsys during the 4th quarter valued at about $504,000. Finally, Brown Brothers Harriman & Co. grew its stake in Synopsys by 6.6% during the fourth quarter. Brown Brothers Harriman & Co. now owns 1,927 shares of the semiconductor company’s stock worth $935,000 after purchasing an additional 119 shares during the period. Institutional investors and hedge funds own 85.47% of the company’s stock.
Synopsys Stock Performance
SNPS stock opened at $437.95 on Friday. The company has a market capitalization of $67.72 billion, a P/E ratio of 30.16, a price-to-earnings-growth ratio of 3.23 and a beta of 1.16. Synopsys, Inc. has a 52-week low of $425.73 and a 52-week high of $624.80. The business has a 50-day simple moving average of $485.62 and a two-hundred day simple moving average of $505.55.
Insider Activity at Synopsys
Analyst Ratings Changes
Several equities analysts have issued reports on SNPS shares. Robert W. Baird dropped their price target on Synopsys from $644.00 to $630.00 and set an “outperform” rating on the stock in a research note on Thursday, December 5th. Piper Sandler dropped their target price on shares of Synopsys from $655.00 to $653.00 and set an “overweight” rating on the stock in a research report on Thursday, February 27th. Morgan Stanley reduced their price target on shares of Synopsys from $625.00 to $590.00 and set an “overweight” rating for the company in a report on Monday, February 24th. Needham & Company LLC reiterated a “buy” rating and set a $650.00 price objective on shares of Synopsys in a report on Thursday, February 27th. Finally, Rosenblatt Securities reissued a “buy” rating and set a $660.00 price objective on shares of Synopsys in a research report on Tuesday, February 25th. One research analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $638.58.
Check Out Our Latest Stock Analysis on Synopsys
Synopsys Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Further Reading
- Five stocks we like better than Synopsys
- Low PE Growth Stocks: Unlocking Investment Opportunities
- MarketBeat Week in Review – 03/24 – 03/28
- What is the MACD Indicator and How to Use it in Your Trading
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- What to Know About Investing in Penny Stocks
- 4 Healthcare Stocks With Massive Gains—and More to Come
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.